دورية أكاديمية
أعرض في EDS

Single centre observational study evaluating the impact of introducing High Flow Nasal Cannula outside of Paediatric Critical Care Unit.

التفاصيل البيبلوغرافية
العنوان: Single centre observational study evaluating the impact of introducing High Flow Nasal Cannula outside of Paediatric Critical Care Unit.
المؤلفون: Patel S; Nottingham University Hospitals, Nottingham, United Kingdom., Hunter J; Nottingham University Hospitals, Nottingham, United Kingdom., Davies P; Nottingham University Hospitals, Nottingham, United Kingdom., Silvestre C; Nottingham University Hospitals, Nottingham, United Kingdom.
المصدر: Journal of paediatrics and child health [J Paediatr Child Health] 2024 Jul; Vol. 60 (7), pp. 303-311. Date of Electronic Publication: 2024 Jun 01.
نوع المنشور: Journal Article; Observational Study
اللغة: English
بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 9005421 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1754 (Electronic) Linking ISSN: 10344810 NLM ISO Abbreviation: J Paediatr Child Health Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Melbourne ; Boston : Blackwell Scientific Publications, c1990-
مواضيع طبية MeSH: Cannula* , Intensive Care Units, Pediatric* , Oxygen Inhalation Therapy*/methods , Oxygen Inhalation Therapy*/instrumentation, Humans ; Retrospective Studies ; Male ; Female ; Infant
مستخلص: Aim: To evaluate the impact of High Flow Nasal Cannula (HFNC) introduction outside of Paediatric Critical Care Units (PCCU), on PCCU admissions and intubation rates. Secondarily, to identify escalation predictors.
Methods: Retrospective observational study with matched PCCU admissions and intubation rates, 2-years before (Group 1) and 2-years after (Group 2) HFNC introduction outside of PCCU. Within Group 2, we compared those admitted to PCCU (escalation) and those who did not (non-escalation). Observations, change in observations and time to starting HFNC were analysed.
Results: Pre- and post-introduction comparison: Of 980 admissions in Group 1, 55 were admitted to PCCU, whereas of 1209 admission in Group 2, there were 85 admissions, P = 0.188. Group 1 had 25 intubations compared to 23 in Group 2, P = 0.309. Over twice as many children had some form of respiratory support in Group 2. Post-introduction: 104 children commenced HFNC, 72% for bronchiolitis. Median age was 4 months in the non-escalation group and 6.5 months in the escalation group, P = 0.663. Thirty-eight children escalated to PCCU: 33 required CPAP/BiPAP, 4 were intubated with 1 remaining on HFNC. Comparisons of age, gender, comorbidities, observations, change in observations and time to starting HFNC showed no significant escalation predictors.
Conclusions: This study identified no statistically significant predictors of escalation. There was an observed increase in PCCU admissions with decreased intubations. The resource implications of this therapy are significant and further studies should examine cost effectiveness of HFNC use outside of PCCU.
(© 2024 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).)
References: Spentzas T, Minarik M, Patters A, Vinson B, Stidham G. Children with respiratory distress treated with high‐flow nasal cannula. J. Intensive Care Med. 2009; 24: 323–328.
Dysart K, Miller T, Wolfson M, Shaffer T. Research in high flow therapy: Mechanisms of action. Respir. Med. 2009; 103: 1400–1405.
Hutchings F, Hilliard T, Davis P. Heated humidified high‐flow nasal cannula therapy in children. Arch. Dis. Child. 2015; 100: 571–575.
Milési C, Pierre A, Deho A et al. A multicenter randomized controlled trial of a 3‐L/kg/min versus 2‐L/kg/min high‐flow nasal cannula flow rate in young infants with severe viral bronchiolitis (TRAMONTANE 2). Intensive Care Med. 2018; 44: 1870–1878.
Doyle L, Anderson P. Pulmonary and neurological follow‐up of extremely preterm infants. Neonatology 2010; 97: 388–394.
Pearson G. Why Children Die: A Pilot Study. Confidential Enquiry into Maternal and Child Health; 2006.
Martin A, Beringer A. Advanced care planning 5 years on: An observational study of multi‐centred service development for children with life‐limiting conditions. Child Care Health Dev. 2019; 45: 234–240.
Franklin D, Babl F, Schlapbach L et al. A randomized trial of high‐flow oxygen therapy in infants with bronchiolitis. N. Engl. J. Med. 2018; 378: 1121–1131.
Schibler A, Pham T, Dunster K et al. Reduced intubation rates for infants after introduction of high‐flow nasal prong oxygen delivery. Intensive Care Med. 2011; 37: 847–852.
McKiernan C, Chua L, Visintainer P, Allen H. High flow nasal cannulae therapy in infants with bronchiolitis. J. Pediatr. 2010; 156: 634–638.
NICE. End of life care for infants, children and young people with life‐limiting conditions: planning and management. 2016. Report No.: NG61.
Lin J, Zhang Y, Xiong L, Liu S, Gong C, Dai J. High‐flow nasal cannula therapy for children with bronchiolitis: A systematic review and meta analysis. Arch. Dis. Child. 2019; 104: 564–576.
Kallappa C, Hufton M, Millen G, Ninan T. Use of high flow nasal cannula oxygen (HFNCO) in infants with bronchiolitis on a paediatric ward: A 3‐year experience. Arch. Dis. Child. 2014; 99: 790–791.
Milési C, Essouri S, Pouyau R et al. High flow nasal cannula (HFNC) versus nasal continuous positive airway pressure (nCPAP) for the initial respiratory management of acute viral bronchiolitis in young infants: A multicenter randomized controlled trial (TRAMONTANE study). Intensive Care Med. 2017; 43: 209–216.
فهرسة مساهمة: Keywords: high Flow Nasal Cannula; non‐invasive ventilation; paediatric Critical Care Outreach Team; paediatric Critical Care Unit
تواريخ الأحداث: Date Created: 20240601 Date Completed: 20240723 Latest Revision: 20240723
رمز التحديث: 20240723
DOI: 10.1111/jpc.16541
PMID: 38822781
قاعدة البيانات: MEDLINE
الوصف
تدمد:1440-1754
DOI:10.1111/jpc.16541